Product Liability Practice: DLA Piper
Heightened scrutiny of the pharmaceutical and medical device industry by Congress and the U.S. Food and Drug Administration isn't going to decline anytime soon, said partners in DLA Piper's product liability...To view the full article, register now.
Already a subscriber? Click here to view full article